Germline microRNA-based signatures predict toxicity and response to anti-CTLA-4 therapy by Joanne B. Weidhaas, Kristen M. McGreevy, Nicholas Marco, Nora Sundahl, Christopher R. Cabanski, Christine Spencer, Theresa LaVallee, Piet Ost, Donatello Telesca

Get full text

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol by P. Travis Courtney, Milisuryani L. Santoso, Ricky R. Savjani, Vishruth K. Reddy, Wanxing Chai-Ho, Maria A. Velez Velez, Deborah J. Wong, Christy Palodichuk, T. Vincent Basehart, Dylan P. O’Connell, Minsong Cao, Donatello Telesca, Robert K. Chin

Get full text

Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy by Santosh Kesari, Jose Carrillo, Alexandra Drakaki, Joanne Weidhaas, Mark Scholz, Nicholas Marco, Aaron W Scheffler, Anusha Kalbasi, Kirk Wilenius, Emily Rietdorf, Jaya Gill, Mara Heilig, Caroline Desler, Robert K Chin, Tania Kaprealian, Susan McCloskey, Ann Raldow, Naga P Raja, Donatello Telesca

Get full text